These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 7907250)

  • 1. Treatment of Waldenstrom's macroglobulinemia with nucleoside analogues.
    Dimopoulos MA; O'Brien S; Kantarjian H; Estey EE; Keating MJ; Alexanian R
    Leuk Lymphoma; 1993; 11 Suppl 2():105-8. PubMed ID: 7907250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fludarabine therapy in Waldenström's macroglobulinemia.
    Dimopoulos MA; O'Brien S; Kantarjian H; Pierce S; Delasalle K; Barlogie B; Alexanian R; Keating MJ
    Am J Med; 1993 Jul; 95(1):49-52. PubMed ID: 8328496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary therapy of Waldenström's macroglobulinemia with 2-chlorodeoxyadenosine.
    Dimopoulos MA; Kantarjian H; Weber D; O'Brien S; Estey E; Delasalle K; Rose E; Cabanillas F; Keating M; Alexanian R
    J Clin Oncol; 1994 Dec; 12(12):2694-8. PubMed ID: 7989946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Waldenstrom's macroglobulinemia resistant to standard therapy with 2-chlorodeoxyadenosine: identification of prognostic factors.
    Dimopoulos MA; Weber D; Delasalle KB; Keating M; Alexanian R
    Ann Oncol; 1995 Jan; 6(1):49-52. PubMed ID: 7710983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fludarabine treatment in resistant Waldenstrom's macroglobulinemia.
    Zinzani PL; Gherlinzoni F; Bendandi M; Zaccaria A; Aitini E; Salvucci M; Tura S
    Eur J Haematol; 1995 Feb; 54(2):120-3. PubMed ID: 7698295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fludarabine in Waldenstrom's macroglobulinemia.
    Souchet-Compain L; Nguyen S; Choquet S; Leblond V
    Expert Rev Hematol; 2013 Jun; 6(3):229-37. PubMed ID: 23782076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fludarabine in Waldenstrom's macroglobulinemia.
    Leblond V; Choquet S
    Semin Oncol; 2003 Apr; 30(2):239-42. PubMed ID: 12720144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fludarabine therapy in a patient with progressive symptomatic Waldenström's macroglobulinemia.
    Hałaburda K; Hellmann A
    Acta Haematol Pol; 1994; 25(1):63-7. PubMed ID: 8209618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2Chlorodeoxyadenosine therapy of patients with Waldenström macroglobulinemia previously treated with fludarabine.
    Dimopoulos MA; Weber DM; Kantarjian H; Keating M; Alexanian R
    Ann Oncol; 1994 Mar; 5(3):288-9. PubMed ID: 7514439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purine analogs in chronic lymphocytic leukemia and Waldenström's macroglobulinemia.
    O'Brien S; Kantarjian H; Keating MJ
    Ann Oncol; 1996; 7 Suppl 6():S27-33. PubMed ID: 9010576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a 2-hour infusion of 2-chlorodeoxyadenosine in the treatment of refractory or previously untreated Waldenström's macroglobulinemia.
    Hellmann A; Lewandowski K; Zaucha JM; Bieniaszewska M; Hałaburda K; Robak T
    Eur J Haematol; 1999 Jul; 63(1):35-41. PubMed ID: 10414453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Chlorodeoxyadenosine alone and in combination for previously untreated Waldenstrom's macroglobulinemia.
    Weber DM; Dimopoulos MA; Delasalle K; Rankin K; Gavino M; Alexanian R
    Semin Oncol; 2003 Apr; 30(2):243-7. PubMed ID: 12720145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fludarabine therapy in Waldenström's macroglobulinemia patients treated previously with 2-chlorodeoxyadenosine.
    Lewandowski K; Halaburda K; Hellmann A
    Leuk Lymphoma; 2002 Feb; 43(2):361-3. PubMed ID: 11999570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Waldenstrom macroglobulinemia with 2-chlorodeoxyadenosine.
    Dimopoulos MA; Kantarjian H; Estey E; O'Brien S; Delasalle K; Keating MJ; Freireich EJ; Alexanian R
    Ann Intern Med; 1993 Feb; 118(3):195-8. PubMed ID: 8093333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-Chlorodeoxyadenosine therapy in Waldenstrom's macroglobulinaemia.
    Delannoy A; Ferrant A; Martiat P; Bosly A; Zenebergh A; Michaux JL
    Nouv Rev Fr Hematol (1978); 1994 Aug; 36(4):317-20. PubMed ID: 7971252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of fludarabine in previously treated Waldenström's macroglobulinemia: a report of 71 cases. Groupe Coopératif Macroglobulinémie.
    Leblond V; Ben-Othman T; Deconinck E; Taksin AL; Harousseau JL; Delgado MA; Delmer A; Maloisel F; Mariette X; Morel P; Clauvel JP; Duboisset P; Entezam S; Hermine O; Merlet M; Yakoub-Agha I; Guibon O; Caspard H; Fort N
    J Clin Oncol; 1998 Jun; 16(6):2060-4. PubMed ID: 9626204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryptococcal meningitis and intracranial tuberculoma in a patient with Waldenstrom's macroglobulinemia treated with fludarabine.
    Costa P; Luzzati R; Nicolato A; Perboni G; Scalzini A; Lazzarini L; Forghieri ME; Aitini E; Zinzani PL
    Leuk Lymphoma; 1998 Feb; 28(5-6):617-20. PubMed ID: 9613995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fludarabine-based combination therapies for Waldenström's macroglobulinemia.
    Tedeschi A; Alamos SM; Ricci F; Greco A; Morra E
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):67-70. PubMed ID: 19362977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New prospects in the treatment of indolent lymphomas with purine analogues.
    Cheson BD
    Cancer J Sci Am; 1998 Jul; 4 Suppl 2():S27-36. PubMed ID: 9672772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab-based treatments in Waldenström's macroglobulinemia.
    Dimopoulos MA; Kastritis E; Roussou M; Eleutherakis-Papaiakovou E; Migkou M; Gavriatopoulou M; Tassidou A; Terpos E
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):59-61. PubMed ID: 19362975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.